The importance of appropriate funding to early stage life science companies cannot be underestimated and whilst it’s great to see many organisations and BIA members successfully securing the investment they need, the political and economic uncertainty currently prevailing does highlight the challenges of navigating choppy waters….

BIA’s UK CEO and Investor Forum this year considers some of the huge challenges and opportunities that present themselves in the context of a new international landscape for innovative life sciences and we are gathering key investors for their views.

Kate Bingham, Partner at SV Health Investors and BIA Lifetime Achievement Award Winner will join us on 24 May for dinner and fireside chat with Steve Bates, BIA CEO, to discuss her career, her views on the sector and challenges of the current external environment.  Kate will also participate in our panel workshop earlier in the day, led by Consilium and providing key tips and advice to delegates on preparing for those all-important investor pitches.  If you’re looking at your next VC round or preparing for the public markets, make sure you sign up…

At current growth rates, China is forecast to overtake the US to become the world’s largest funder of R&D in 2022.  In our panel, Investment from the East – what are the real opportunities for Biotech? we look at current and future opportunities and discuss the realities of investment from China with seasoned investors and companies who have been there and done it…. John Hodgson from Informa chairs the session with biotech stalwart’s Dr David Chiswell (CEO, Kymab) and Dr Andy Richards, and seasoned China experts Peter Crane (CEO, Rare Pharma), Simon Haworth (Founder, Dynasty Bio) and Rob Scott (China Bluesky).

Closer to home we take a more in-depth look at the Future of Funding for UK Biotech, exploring additional innovative forms of funding and discussing the funding gaps that persist – with session chair David Mardle (Partner, Taylor Wessing), Richard Jones (CFO, Mereo Biopharma), David Pinniger (Fund Manager, Polar Capital) and Phil Walker (Head of Healthcare Corporate Finance, Zeus Capital) – and Alice Wu-Wagner (MD, Strategy Economics and BD, BBB) explains how the British Business Bank is funding innovative companies in the UK.

Click here for a full programme and join us 24-25 May at The Belfry, Milton Common, Oxfordshire for two-days of thought-leadership and networking with C-level industry peers, investors and other key sector stakeholders.